Showing results (41-50 of 243) with videos related to

Sort By:
Pageof 25
Molecular Cancer Therapeutics|September 17, 2009
Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cellsYoung-Kwang Yoon, Hwang-Phill Kim, Sae-Won Han, et al.
Cancer Letters|November 16, 2011
Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cellsYoung-Kwang Yoon, Hwang-Phill Kim, Sang-Hyun Song, et al.
Nutrition and Cancer|June 11, 2016
Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative ChemotherapyDae-Won Lee, Kyung-Hun Lee, Tae-Yong Kim, et al.
Cancer Letters|February 14, 2013
OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cellsMi-Jung Kim, Hyun-Jin Nam, Hwang-Phill Kim, et al.
International Journal of Oncology|April 30, 2010
DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cellsHeesun Kim, Jinah Park, Yeonjoo Jung, et al.
Plos One|May 8, 2020
Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencingJun-Kyu Kang, Sunghoon Heo, Hwang-Phill Kim, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 24, 2015
Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implicationsChan-Young Ock, Tae-Yong Kim, Kyung-Hun Lee, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2018
A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivitySoo Jie Chung, Sung-Yoon Kang, Rae-Young Kang, et al.
Clinical Epigenetics|April 7, 2016
Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patientsDuo Chen, Xianyu Wen, Young Seok Song, et al.
Histology and Histopathology|July 12, 2024
Clinicopathological and molecular features of genome-stable colorectal cancersLingyan Jin, Hye-Yeong Jin, Younghoon Kim, et al.
Pageof 25